Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Escherichia coli heat-stable enterotoxin (ST) is a small, cysteine-rich peptide produced by enterotoxigenic Escherichia coli (ETEC) that acts as a potent secretagogue in the mammalian intestine (UniProt: P01559). It primarily exists in two forms, STa and STb, with STa being the primary cause of traveler's diarrhea in humans by mimicking the endogenous paracrine hormones guanylin and uroguanylin (PubMed: 28416774). Upon entering the intestinal lumen, STa binds with high affinity to the extracellular domain of the transmembrane receptor Guanylate Cyclase C (GC-C) located on the apical surface of enterocytes (PubMed: 25827302). This binding triggers an increase in intracellular cyclic guanosine monophosphate (cGMP), which activates protein kinase G II (PKGII) and inhibits phosphodiesterase 3, leading to the activation of the cystic fibrosis transmembrane conductance regulator (CFTR) chloride channel and the inhibition of the sodium-hydrogen exchanger 3 (NHE3) (StatPearls: ETEC). The resulting net secretion of chloride and bicarbonate ions, along with the inhibition of sodium absorption, creates an osmotic gradient that draws water into the intestinal lumen, causing watery diarrhea (PubMed: 30205260). While the toxin itself is a virulence factor, its pathway has been exploited therapeutically; synthetic analogs like Linaclotide and Plecanatide are used to treat chronic idiopathic constipation and irritable bowel syndrome with constipation (IBS-C) by activating the same GC-C receptor (FDA Label: Linzess).
Binding and activation of the transmembrane receptor Guanylate Cyclase C (GC-C) on intestinal epithelial cells, which stimulates the production of cGMP to induce electrolyte and fluid secretion.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Escherichia coli heat-stable enterotoxin (STa).